Delving into the Latest Updates on Copharos, Inc. with Synapse

概览

关联

1

项与 Copharos, Inc. 相关的药物

Radiolabeled DTPA-adenosylcobalamin(University of Minnesota)

靶点-

作用机制

SPECT

在研机构-

原研机构

University of Minnesota

在研适应症-

非在研适应症

脑癌 [+5]

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

2

项与 Copharos, Inc. 相关的临床试验

NCT00040430 / Unknown status临床1期

Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer

The purpose of this study is to investigate the safety and imaging ability of 111In-DAC when used with planar and SPECT imaging for the detection of breast cancer.

开始日期-

申办/合作机构

Copharos, Inc.

NCT00040560 / Unknown status临床1期

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

The purpose of this study is to investigate the safety and imaging ability of 111In-DAC when used with planar and SPECT imaging for the detection of lung cancer and brain cancer consistent with metastatic lung cancer.

开始日期-

申办/合作机构

Copharos, Inc.

100 项与 Copharos, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Copharos, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Copharos, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Copharos, Inc. 相关的转化医学

登录后查看更多信息